Bogdan Balas

机构：PIQUR Therapeutics (Switzerland) · ORCID：0000-0002-2384-9096

发表论文 56 篇 · 总被引 4816 次 · h-index 20

代表论文

• Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study (2018 · Annals of Oncology · 被引 350)
• Alectinib versus crizotinib in treatment-naive anaplastic lymphoma kinase-positive (ALK+) non-small-cell lung cancer: CNS efficacy results from the ALEX study (2018 · Annals of Oncology · 被引 330)
• Real-World Treatment Patterns of Sacubitril/Valsartan: A Longitudinal Cohort Study in Germany (2019 · European Journal of Heart Failure · 被引 66)
• Primary results from the phase III ALUR study of alectinib versus chemotherapy in previously treated ALK+ non-small-cell lung cancer (NSCLC) (2017 · Annals of Oncology · 被引 23)
• Early insights into the characteristics and evolution of clinical parameters in a cohort of patients prescribed sacubitril/valsartan in Germany (2018 · Postgraduate Medicine · 被引 22)
• Perceptions of heart failure symptoms, disease severity, treatment decision-making and side effects by patients and cardiologists: a multinational survey in a cardiology setting (2018 · Therapeutics and Clinical Risk Management · 被引 21)